Jared Gollob, Chief Medical Officer: Kymera Therapeutics KYMR Sell · Filed 03/04

Trade details

Type: Insider sale
Amount: $214,215.76
Shares · price: 2,519 sh · $85.04 a share
Held after: 119,018 sh
Stock: Kymera Therapeutics KYMR
Person: Jared GollobChief Medical Officer
Trade date: 26/03/04
Filed: 26/03/04
Days to filing: 0 days

Sold 2.1% of holdings

Share of holding sold: 2.1%

Kymera Therapeutics trades, last 26 weeks

What else happened in Kymera Therapeutics around then

Filed or reported within 30 days of the trade day · 02/02~04/03

Jared Gollob's recent trades

Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$273.3K
3,048 sh
$273.3K
Filed 03/04
Traded 03/02
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$132.5K
1,510 sh
$132.5K
Filed 03/04
Traded 03/02
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$123.3K
1,437 sh
$123.3K
Filed 03/04
Traded 03/04
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$93.4K
1,055 sh
$93.4K
Filed 03/04
Traded 03/02
Jared GollobChief Medical Officer
SellKymera Therapeutics
Sell
Kymera Therapeutics
KYMR
$41.3K
492 sh
$41.3K
Filed 03/04
Traded 03/04